Abstract
BackgroundThe treatment of rheumatoid arthritis (RA) has been transformed by the development of novel agents targeting biological factors. The idea of “treat to target” has emerged. Early aggressive treatment with...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
